Sarcoidosis and Gas Exchange Measures
To the Editor:
Dr. Medinger and her colleagues are to be commended for presenting data assessing the severity of sarcoidosis in 48 patients by using cardiopulmonary exercise testing with gas exchange measurements (July 2001). 1 They noted that abnormalities in resting diffusing capacity of the lung for carbon monoxide (Dlco) [an index of pulmonary capillary blood volume and maldistribution of ventilation] and peak exercise alveolar-arterial oxygen pressure difference (P[A-a]O 2 ) [an index of impaired oxygen transfer] correlated especially well with the severity of radiographic findings.
Their collected data include arterial blood analyses and concurrent measurements of end-tidal Pco 2 and mixed expired carbon dioxide at peak exercise. Accordingly, it would be relatively simple for them to retrospectively calculate the concurrent peak exercise arterial-end tidal Pco 2 P(a-et)CO 2 and dead space/tidal volume ratio (Vd/Vt), both indexes of wasted ventilation. 2 In our experience, exercise P(a-et)CO 2 and Vd/Vt both correlate with the severity of interstitial lung disease and abnormalities in resting Dlco and exercise P(A-a)O 2 , and are more frequently abnormal than P(A-a)O 2 . 3,4 Yet, as previously noted, 3,4 neither exercise P(a-et)CO 2 nor Vd/Vt tend to be calculated by many other investigators even when necessary data were available to them. Therefore, I encourage these investigators to calculate and correlate these two exercise indexes of wasted ventilation, P(a-et)CO 2 and Vd/Vt, with their other reported measurements in their 48 patients. To the Editor:
James E. Hansen, MD
We appreciate Dr. Hansen's observations about our recent report of exercise measurements in 48 patients with sarcoidosis. 1 Drs. Hansen and Wasserman concluded from their own analysis of exercise testing, in 42 patients with a variety of interstitial lung diseases, that pulmonary vascular disease was a more significant impairment than ventilatory restriction in their patients. 2 The objective of their analysis was to determine the pathophysiologic factor limiting peak exercise performance. They found that exercise impairment had a better negative correlation with the peak physiological dead space ventilation (P Vd/Vt) than with peak Pao 2 (P Pao 2 ). Furthermore, they found an excellent correlation of P Vd/Vt with peak arterial end-tidal cartoon dioxide pressure difference [P P(a-et)Co 2 ], and of P Pao 2 with peak alveolar-arterial oxygen pressure difference [P P(A-a)o 2 ].
The objective of our analysis was more pedestrian, namely the determination of a sensitive test to follow extent of disease in patients with sarcoidosis. Reviewing our data to analyze P Vd/Vt and P P(a-et)Co 2 measurements, we found that P Vd/Vt correlated only moderately with P P(a-et)Co 2 (r ϭ 0.82), and that P Pao 2 correlated well with P P(A-a)o 2 (r ϭ 0.97). P Vd/Vt was calculated using the arterial and concomitant mixed expired Co 2 measurements at the point of P P(a-et)Co 2 measurement. Table  1 shows the level of significance (calculated p) of these additional measurements relative to the radiographic extent of disease, across all radiographic stages of sarcoidosis (0 -4) and across limited stage disease (0 -2). We used a single factor analysis of variance (p ϭ 0.05). The P Vd/Vt and P P(a-et)Co 2 are significant across all radiographic stages of sarcoidosis. However, in contrast to our finding for the P P(A-a)o 2 data (⌬P(A-a)o 2 /⌬V o 2 ), the significance of Vd/Vt and P(a-et)Co 2 is lost by subtracting the resting measurements from each and factoring the change in V o 2 .
Furthermore, we found that the P Vd/Vt correlated only moderately well with the diffusion measurements in the 30 patients with matched data (r ϭ 0.78 for all radiographic stages; 0.65 for stages 0 -2). P P(a-et)Co 2 did not correlate well with radiographic stage (r ϭ 0.47). ⌬P(A-a)o 2 /⌬V o 2 had the best correlation with diffusion in these patients (r ϭ 0.88 for all stages and 0.81 for stages 0 -2).
Hansen and Wasserman's article 2 included 4 of 41 patients with sarcoidosis. Most of their patients had asbestosis, pulmonary alveolar proteinosis, and idiopathic interstitial lung disease, all of which have a lower lobe predilection. Our patients all had biopsy-proven sarcoidosis, which characteristically involves the upper lobes of the lung. The upper lobes have a higher resting ventilation/perfusion ratio (V /Q ) state than the lower lobes. Hence, interstitial disease favoring this region may have a relatively greater tendency to reduce overall V /Q ratio than to reduce perfusion during exercise. This may explain our finding of greatest significance in the association of ⌬P(A-a)o 2 /⌬V o 2 with the radiographic stage in stages 0 -2 sarcoidosis. 
